You are here

Article Text

Article menu
Download PDFPDF
Editorial
Inhaled corticosteroid responses in COPD: do mast cells hold the answer?

https://doi.org/10.1136/thorax-2022-219534

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors Both authors contributed equally to this work.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests DS has acted as a consultant for Aerogen, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, CSL Behring, EpiEndo, Genentech, GlaxoSmithKline, Glenmark, Gossamer Bio, Kinaset Therapeutics, Menarini, Novartis, Orion, Pulmatrix, Sanofi, Teva, Theravance Biopharma and Verona Pharma.

    • Provenance and peer review Commissioned; externally peer reviewed.

    Linked Articles